Medpace Strengthens Medical Leadership Team in Neuroscience with the Addition of New Physician

Medpace is pleased to announce the addition of a new medical expert to its neuroscience medical leadership team. Our unique, scientifically-driven approach to clinical research gives Sponsors the advantage of early and ongoing insight and guidance from trial design through execution of the study. With the addition of this highly-qualified physician, Medpace can offer Sponsors even deeper expertise across a broad spectrum of diseases and technologies. 

About Boban Joksimovic, MD, PhD, Medical Director

Dr. Boban Joksimovic is a board-certified neurologist with a PhD in neuroscience and over 20 years of clinical experience in neurology. Prior to joining Medpace, Dr. Joksimovic worked at a CRO as a Medical Director, Clinical Operations Lead, and CRA with over 17 years of experience in Phase I-IV studies. He previously practiced as a neurophysiologist and introduced intraoperative neurophysiology to Serbia in 2008. Dr. Joksimovic has extensive experience as Sub-investigator and rater in CNS studies. 

What drew you to Medpace?

At large CROs I felt like a number, but at Medpace I feel like part of a team who share a common goal to accelerate the development of safe and effective medical therapeutics. The Medpace team has a passion for their work and strive to make an impact. The managers and my peers have been supportive and friendly from my very first day at Medpace. 

From a clinical development standpoint, what new innovations are you most excited about? 

There are many new innovations in the neuroscience space. The new innovations that I am most excited about are nucleic acid therapeutics and named patient use studies. Medpace is running a number of clinical trials with these drugs.

Accelerating Global Neuroscience Clinical Development

Neuroscience clinical research is a key therapeutic focus for Medpace, a full-service clinical research organization (CRO). Medpace has extensive experience in phase I-IV neuroscience clinical trials spanning adult and pediatric populations in a wide range of neuroscience indications. Leverage our broad experience in advancing new neuroscience treatments and specialized expertise in the design and management of complex neuroscience programs to keep your trial on time and on budget.